Clene Inc. (NASDAQ: CLNN) announced that the Food and Drug Administration stated the company's proposed data may support submission of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE